October 8, 2019— When the health professionals at Kootenai Health send a patient home, one of their main goals is not to see that patient back in the hospital again any time soon. That’s why the 299-bed medical center in rural northern Idaho utilizes its 340B savings to ensure that discharged patients obtain the medications they need to stay healthy at home, especially if they … [Read more...]
Meet Some of the Champions of 340B
Sept. 26, 2019— When one discusses the 340B drug pricing program, the talk often turns to complex compliance and implementation issues such as actual acquisition prices, split billing software, and penny pricing. But it’s important to remember that there also are dedicated people working with all this complexity to make the program a success in helping patients. We recently … [Read more...]
340B May Curb High Drug Prices, New JAMA Study Finds
July 9, 2019– The 340B drug pricing program may discourage drug manufacturers from raising prices and instead may have the effect of reducing list prices for certain drugs. That’s according to a new study published in the Journal of the American Medical Association (JAMA). Study authors Sean Dickson of West Health and Ian Reynolds of the Pew Charitable Trusts evaluated the … [Read more...]